Abbott India Limited vs Persistent Systems Limited
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Abbott India Limited (Pharmaceuticals) and Persistent Systems Limited (Information technology services and digital engineering) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, Persistent Systems Limited leads on Revenue (approx.).
Persistent Systems Limited leads on Revenue (approx.).
Choose Abbott India if you prefer exposure to branded pharmaceuticals with established doctor and pharmacy distribution, strong parentage, and focus on higher-margin formulations. Choose Persistent Systems if you want exposure to digital engineering, cloud, data, and AI-led transformation services with global client reach. The right choice depends on whether the buyer prioritizes domestic pharma stability and brands or IT services growth tied to technology spending cycles.
Grounded in the verified figures and SWOT shown — guidance, not investment advice.
Head-to-head highlights
| Metric | Abbott India Limited | Persistent Systems Limited | Basis |
|---|---|---|---|
| Revenue (approx.) | INR 5,800-6,200 crore | Approximately US$1.1 billion to US$1.3 billion, unverified rough range | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Abbott India Limited
Pharmaceuticals · India
Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories. It markets branded prescription and over-the-counter healthcare products across therapeutic areas such as gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
Verified financials
No source-verified financials available.
Strengths
- Strong parentage from Abbott Laboratories
- Recognized brands in chronic and specialty therapeutic areas
- Established doctor and pharmacy distribution network
- Focus on higher-margin branded formulations
Weaknesses
- High dependence on the Indian domestic pharmaceutical market
- Limited scale compared with India's largest pharma companies
- Exposure to price controls on essential medicines
- Relatively concentrated portfolio in select therapies
Opportunities
- Growth in chronic disease treatment demand in India
- Expansion in women's health, gastroenterology, and metabolic care
- Digital engagement with physicians and patients
- Leveraging Abbott's global portfolio for India-specific launches
Threats
- Intense competition from Indian generic and branded-generic companies
- Regulatory pricing pressure from India's drug price control regime
- Changes in physician prescribing behavior
- Supply chain and input cost volatility
Persistent Systems Limited
Information technology services and digital engineering · India
Persistent Systems Limited is an India-headquartered technology services company focused on digital engineering, software product development, cloud, data, and enterprise modernization. It serves clients across sectors such as banking and financial services, healthcare and life sciences, technology, and industrial markets.
Verified financials
No source-verified financials available.
Strengths
- Strong positioning in digital engineering and software product development
- Established presence in cloud, data, and AI-led transformation services
- Deep experience serving technology, BFSI, and healthcare clients
- India-based delivery model with global client reach
Weaknesses
- Smaller scale than the largest global IT services firms
- Revenue exposure to discretionary technology spending cycles
- Dependence on skilled talent in competitive engineering labor markets
- Brand recognition outside specialist IT services circles is lower than top-tier peers
Opportunities
- Growing demand for AI, cloud, and data modernization services
- Expansion in enterprise software ecosystems such as Salesforce, Microsoft, AWS, and Google Cloud
- Increased outsourcing of product engineering by software and technology companies
- Cross-selling managed services and modernization work to existing clients
Threats
- Pricing pressure from larger IT services competitors
- Slowdowns in client technology budgets
- Talent attrition and wage inflation
- Rapid shifts in AI and automation that could disrupt traditional service delivery models
Frequently asked
Answered from source-verified figures on this page.
Abbott India Limited vs Persistent Systems Limited: which company leads overall?
Persistent Systems Limited leads on Revenue (approx.).
Related market reports
Deep-dive intelligence on the markets these companies compete in.
India Digital Payments Market — Intelligence Report
Global Digital Payments & Real-Time Rails Market — Intelligence Report
Tokenized Real-World Assets and Digital Securities Market — Intelligence Report
Global Tokenized Real-World Assets, Digital Bonds and On-Chain Fund Administration Market — Intelligence Report
AI Analyst
Insights and answers generated live from Abbott India Limited vs Persistent Systems Limited's verified data. Modeled estimates — not investment advice.
- Abbott India Limited is an Indian pharmaceutical company and listed subsidiary of Abbott Laboratories.
- Abbott India markets branded prescription and over-the-counter healthcare products across areas including gastroenterology, women's health, metabolic disorders, CNS, pain management, and vaccines.
- Persistent Systems Limited is an India-headquartered IT services and digital engineering company focused on software product development, cloud, data, and enterprise modernization.
- Notable: Both companies operate from India but serve different sectors, with Abbott India in pharmaceuticals and Persistent Systems in technology services.